OncoZero.AI is a NN-powered software for early abdominal cancer and fast leukaemia diagnosis, which makes it 4 times faster and 20% more accurate. Our initiative is based on cancer diagnosis - a long process that takes too much time and is not always accurate. Roughly 40% of cancer cases are misdiagnosed due to the deficit of qualified specialists (25% globally) and lack of expensive medical devices. We have created two softwares that are solving this issue.
In case of abdominal cancer, we have built OncoZero.V1 - a neural network that analyses computer tomography images and finds cancer on early stages using algorithms based on 5,000 patients from all over the world. This software has 90% accuracy and allows to scan the whole abdomen (bowl) in just 55 seconds, which makes the cumulative process more than 4 times faster and increases early stage cancer detection by 77%.
Our second software aims to accelerate leukaemia diagnosis and make it more accessible. Leukaemia diagnosis requires a genetic analysis to classify disease type and find proper treatment. In case of developed countries the analysis can be done using FISH-analysis or NGS-sequencing. Both these analysis require up to 21 days to process and cost from 500-3000$ to patients because of the expensive consumables and even more expensive machinery. We have developed the software that detects 4 different types of genetic mutations based on white blood cells (later WBC) images and requires only a microscope. Neural networks analyse WBC appearance and predict results of genetic analysis with 99.7% accuracy. This is an alternative to a technology that costs millions of dollars and will allow to diagnose leukaemia in rural areas and in developing countries a thousand times cheaper and a million times faster.
At this point, our project has analysed more than 5 thousand radiological patients all across the Kazakhstan, and more than 3 thousand leukaemia patients in all of the Central Asia.

https://oncozero.vercel.app/

• Kazakhstan
• Uzbekistan

• The poor
• Adult
• Every oncological patient in the world

I truly believe that OncoZero.AI is a highly sustainable initiative because it significantly impacts healthcare accessibility, cost reduction, and improved efficiency in cancer diagnosis.
OncoZero.AI addresses the global shortage of qualified oncologists (25% deficit) and the lack of advanced medical equipment, particularly in developing regions.The leukaemia diagnosis software, which only requires a basic microscope, offers an affordable alternative to costly genetic analysis, drastically reducing financial barriers for patients.
OncoZero.V1 scans the entire abdomen in just 55 seconds with 90% accuracy, significantly improving early-stage cancer detection rates by 77%, while leukaemia diagnosis software provides results in real-time, eliminating the 21-day waiting period associated with genetic testing.

OncoZero.AI aligns with WSIS values by transforming cancer diagnosis through AI-driven healthcare solutions, particularly in Kazakhstan and Central Asia. 1. Bridging the Digital Divide & Promoting E-Health (WSIS Action Line C7) - OncoZero.AI brings AI-powered cancer diagnostics to underserved communities, eliminating the need for expensive medical infrastructure. 2. Accessibility & Affordability of Medical Technologies (WSIS Action Line C3) - Traditional methods like FISH-analysis and NGS sequencing cost $500–$3,000 and take up to 21 days. OncoZero.AI’s AI-based alternative provides results instantly, making it 1000x cheaper and millions of times faster.